诺泰生物 (688076.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(诺泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 355,815,137.721,033,548,079.03709,466,382.95400,781,544.83208,058,681.69651,291,707.66382,238,680.01268,300,406.36134,246,184.41
 营业利润(元) 80,820,160.49189,665,794.91121,070,282.0454,164,718.8829,113,137.96124,851,517.4643,582,109.7426,358,665.8015,279,707.80
 利润总额(元) 80,450,710.62173,126,873.98114,846,980.2247,875,645.0523,528,055.19123,158,229.5042,383,975.9824,965,530.9214,930,312.73
 净利润(元) 64,564,924.95165,452,661.9690,339,373.1139,851,244.7918,885,415.84122,770,521.5448,653,233.8431,982,892.2414,993,326.89
 归属于母公司股东的净利润(元) 66,326,817.02162,936,105.2591,712,811.5441,852,470.8521,012,921.56129,106,565.5253,194,884.8834,833,587.6816,093,060.08
盈利能力:
 销售毛利率(%) 67.2660.9760.6957.5955.9357.5753.7752.6854.23
 销售净利率(%) 18.1516.0112.739.949.0818.8512.7311.9211.17
 净资产收益率(%) 3.177.994.822.251.12----
 总资产报酬率ROA(%) 2.656.094.632.101.16----
 投入资本回报率ROIC(%) 2.035.983.771.780.906.102.571.700.81
营运能力:
 存货周转率(次) 0.321.150.820.550.31----
 应收账款周转率(次) 1.423.822.952.171.41----
 总资产周转率(次) 0.110.340.270.160.09----
偿债能力:
 资产负债率(%) 39.0138.2831.8426.5225.0223.6922.1421.2315.43
 股东权益比率(%) 60.5061.1867.6672.9874.5075.7377.1778.7784.74
 已获利息倍数(倍) 25.7915.9415.8313.666.78-752.24-6.38-5.63-13.29
 流动比率 1.461.541.191.521.811.912.112.403.55
 速动比率 1.031.110.760.981.251.291.401.722.56
发展能力:
 营业收入增长率(%) 71.0258.6985.6149.3854.981.15-15.03-13.17-19.22
 营业利润增长率(%) 177.6151.91177.80105.4990.53-2.70-48.89-56.33-67.35
 税后利润增长率(%) 215.6526.2072.4120.1530.5711.89-27.41-32.25-59.45
 净资产增长率(%) 16.4913.617.475.215.665.463.754.0981.90
 总资产增长率(%) 43.4540.6422.5713.5620.1918.5917.2617.1555.13

前瞻产业研究院